BioPharma Dive 20 may 2026 After raising $800M, Parabilis seeks an IPO to pursue ‘undruggable’ targets
Vertex 20 may 2026 Vertex Pharma stock (US92532F1003): cystic fibrosis leader eyes gene-editing future - AD HOC NEWS
FierceBiotech 20 may 2026 With $30M launch, Oorja Bio breathes new life into South Korean fibrosis candidate
FierceBiotech 20 may 2026 Lilly pens $202M deal for preclinical DNA delivery biotech Engage as M&A streak continues
Amgen 20 may 2026 Amgen CFO Transition as Peter Griffith Retires, Thomas Dittrich Returns - Contract Pharma
Pfizer 20 may 2026 Pfizer’s next-gen pneumonia shot beats Prevnar 20; Relay targets $175M - Endpoints News
Qiagen 20 may 2026 Qiagen links with chip giant Nvidia to propel AI use in drug discovery - Fierce Biotech
Eli Lilly 20 may 2026 Lilly pens $202M deal for preclinical DNA delivery biotech Engage as M&A streak continues - Fierce Biotech
BioPharma Dive 20 may 2026 Immunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing update